Latest Industry Press Releases More...

Our portal’s perpetual and fresh feed of latest happenings in the Pharmaceutical Industry is presented through the Press Releases section, which help our clients to gain a good sense of the current trade environment. This information is instrumental for future strategies.

Press Releases

Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or…

Press Releases

Research and Markets has announced the addition of the "Personalized Cancer Vaccines Market & Clinical Innovation Outlook 2022" report to their offering. The report throws a light over the clinical relevance of personalized forms and identifies the risk and commercial aspects along with the potential outcome for the success of…

Press Releases

Merrimack Pharmaceuticals, Inc. today announced that the company will host its Fourth Quarter 2016 investor conference call and webcast at 8:30 a.m., Eastern time, on Wednesday, March 1.    The call will cover an update on Merrimack's recent progress as well as a summary of fourth quarter and full year…

Press Releases

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss and network over 40 presentations and case studies focusing on the key issues in large molecule and small molecule drug formulation and drug delivery See Agenda with speakers & presentations. Large Molecule Formulations:…

Press Releases

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical study of its lead product candidate, ATX-MS-1467, for the treatment of patients with multiple sclerosis. The Phase IIa, open-label, one arm study evaluated the effects of…

Press Releases

CohBar, Inc., a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it has completed a study to evaluate the potential efficacy of its lead drug candidates, MOTS-c peptide analogs CB4209 and CB4211, in a well-established preclinical model of nonalcoholic steatohepatitis…

Press Releases

Alberty Drugs, a leading Compounding Pharmacy in Batavia, NY has announced a significant shift in focus by concentrating the efforts of their compounding and wellness programs to servicing local Veteran Affairs Centers (VA) and other Federal Agencies. With added constraints on budgets and an increased need to secure cost effective…

Press Releases

According to a new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37…

Press Releases

Hutchison China MediTech Limited (“Chi-Med”)  today announces that a Phase II study of savolitinib has been initiated in locally advanced or metastatic pulmonary sarcomatoid carcinoma (“PSC”) in China. Savolitinib is a highly selective and potent oral c-Met inhibitor with global first-in-class potential. The first drug dose was administered on February…

Press Releases

Nektar Therapeutics today announced that positive Phase 1 clinical data for Nektar's lead immuno-oncology agent, NKTR-214, in patients with renal cell carcinoma (RCC) were presented at ASCO GU 2017.  NKTR-214 is an investigational immuno-stimulatory therapy designed to expand specific cancer-fighting T cells and Natural Killer (NK) cell abundance directly in…

loader